Cas:2298-48-8 3-(4-Morpholinyl)-1-phenyl-1-propanone manufacturer & supplier

Chemical Name:3-(4-Morpholinyl)-1-phenyl-1-propanone

CAS.NO:2298-48-8

Synonyms:1-Propanone, 3-(4-morpholinyl)-1-phenyl-;1-phenyl-3-morpholino-1-propanone;3-(morpholin-4-yl)-1-phenylpropan-1-one;3-Morpholino-1-phenyl-propan-1-on;3-(Morpholin-4-yl)-1-phenylpropan-1-on;3-Morpholinopropiophenone hydrochloride;3-morpholino-1-phenylpropan-1-one;3-morpholin-4-yl-1-phenyl-propan-1-one;3-Morpholino-1-phenyl-1-propanon;3-(4-Morpholinyl)-1-phenyl-1-propanone

Molecular Formula:C₁₃H₁₇NO₂

Molecular Weight:219.280

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:356.9±27.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.531

PSA:29.54000

Exact Mass:219.125931

LogP:1.35

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-Propanone, 3-(4-morpholinyl)-1-phenyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(4-Morpholinyl)-1-phenyl-1-propanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(4-Morpholinyl)-1-phenyl-1-propanone Use and application,3-(4-Morpholinyl)-1-phenyl-1-propanone technical grade,usp/ep/jp grade.

Related News: In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. . 3-(4-Morpholinyl)-1-phenyl-1-propanone manufacturer This also includes its anti-tau pipeline, with the FDA’s approval having “implications for AD programmes targeting Tau,” according to Jefferies. 3-(4-Morpholinyl)-1-phenyl-1-propanone supplier In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. . 3-(4-Morpholinyl)-1-phenyl-1-propanone vendor At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth. 3-(4-Morpholinyl)-1-phenyl-1-propanone factory This also includes its anti-tau pipeline, with the FDA’s approval having “implications for AD programmes targeting Tau,” according to Jefferies.